{
    "medicine_id": "5cd1cb848418aae8203d96113a7c7338025b7aed",
    "platform_id": "DB08888",
    "metadata": {
        "name": "Jetrea 0 5 mg 0 2ml Injection solution concentrate",
        "composition": "0 5 mg 0 2ml Ocriplasmin",
        "clinical_particulars": {
            "therapeutic_indications": "Ocriplasmin is a proteolytic enzyme indicated for the treatment for symptomatic vitreomacular adhesion",
            "contraindications": {
                "disease": "The most commonly reported reactions 5 in patients treated with ocriplasmin were vitreous floaters conjunctival hemorrhage eye pain photopsia blurred vision macular hole reduced visual acuity visual impairment and retinal edema",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}